SEC Form 4 research

Crinetics Pharmaceuticals, Inc. insider transactions

Recent insider disclosures

Officers and directors in the directory

• Okey Stephanie — 11 qualifying
• Hassard James — 4 qualifying
• Knight Jeff E. — 11 qualifying
• Schilke Tobin — 20 qualifying
• Krasner Alan Seth — 6 qualifying
• Fust Matthew K — 53 qualifying
• Wilson Marc — 9 qualifying
• Pizzuti Dana — 21 qualifying
• Betz Stephen F. — 53 qualifying
• Vivaldi Coelho Rogerio — 13 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.